The organization widely regarded as the leading authority on transgender medical treatment is facing allegations from the Federal Trade Commission that it built influential treatment guidelines for minors on evidence its own leaders privately acknowledged was limited and uncertain.The complaint, filed in a Texas federal court by the Federal Trade Commission and the attorneys general of Alaska, Iowa, Nebraska and Texas, accuses World Professional Association for Transgender Health (WPATH) of developing and promoting guidance that healthcare providers relied upon when recommending puberty blocke...
HALO NEWSLETTER
Join HALO today and unlock this story instantly — It's Free